| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.27 | 6e-09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.31 | 5e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |